Bayberry Capital Partners LP Quidel Ortho Corp Transaction History
Bayberry Capital Partners LP
- $243 Million
- Q3 2024
A detailed history of Bayberry Capital Partners LP transactions in Quidel Ortho Corp stock. As of the latest transaction made, Bayberry Capital Partners LP holds 528,000 shares of QDEL stock, worth $23.1 Million. This represents 9.93% of its overall portfolio holdings.
Number of Shares
528,000Holding current value
$23.1 Million% of portfolio
9.93%Shares
1 transactions
Others Institutions Holding QDEL
# of Institutions
292Shares Held
67.7MCall Options Held
337KPut Options Held
134K-
T. Rowe Price Investment Management, Inc. Baltimore, MD9.4MShares$412 Million0.26% of portfolio
-
Carlyle Group Inc. Washington, DC8.26MShares$362 Million56.7% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.05MShares$265 Million0.01% of portfolio
-
Black Rock Inc. New York, NY4.89MShares$215 Million0.0% of portfolio
-
Rubric Capital Management LP New York, NY4.2MShares$184 Million5.33% of portfolio
About QuidelOrtho Corp
- Ticker QDEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 66,952,900
- Market Cap $2.94B
- Description
- QuidelOrtho Corporation focuses on the development and manufacture of diagnostic testing technologies across the continuum of healthcare testing needs. The company operates through Labs, Transfusion Medicine, Point-of-Care, and Molecular Diagnostics business units. The Labs business unit provides clinical chemistry laboratory instruments and tes...